The newest developments in artificial intelligence and cybersecurity are on display at GITEX Global 2024. “Cybersecurity Day,” which kicked off the event on Wednesday, covered the landscape of rising threats, counter-infringement tactics, and technologies that companies need in an increasingly digital world.
In the meantime, the most innovative developments influencing the future of industry and society were showcased at yesterday’s “AI Super Tuesday” event devoted to AI technology and advancements.
The world may soon see the biggest change in medicine since the invention of contemporary drugs, when AI becomes the primary focus of drug discovery. However, given these quick developments, experts debated whether the AI revolution is imminent or more distant than some believe at a captivating Tuesday session titled “The Next Leap in Medicine: Are we on the Edge of a Breakthrough?
Drug discovery typically takes ten to fifteen years, and a single project can cost between $1.5-2 billion, according to Dr. Shameer Khader, Global Head and Executive Director – Computational Biology Cluster, Precision Medicine and Computational Biology at multinational pharmaceutical giant Sanofi. Can you sustain that? The paradigm needs to shift, and we should utilise AI’s potential and benefits throughout the ecosystem. We should optimise every procedure to lower research costs, simplify the drug discovery lifestyle, and create disease models and infrastructure.
Also Read:
Am I Tech Enough Redefines You Are Tech Enough: Tan Ting (Grace) Tang
